2型糖尿病に関連する神経変性におけるIGF1Rシグナリングのメカニズムと運動の治療効果
Zhenlin Mao1, Ming Gong2,3, Xinyue Sun4
1Department of Neurology, Jinan University Affiliated Guangzhou Red Cross Hospital, Guangzhou, Guangdong, China.
European journal of medical research
|August 30, 2025
まとめ
2型糖尿病 (T2D) は神経変性疾患のリスクを高めます. この研究では,インスリン類似成長因子1受容体 (IGF1R) が伝統的な中国医学 (TCM) を通じて調節され,運動は炎症を軽減し,生存を促進することによって神経細胞を保護することを示しています.
科学分野:
- 神経科学と内分泌学
- 代謝と神経変性疾患の研究
背景:
- 2型糖尿病 (T2D) は,アルツハイマー病 (AD) を含む神経変性疾患 (ND) のリスクの増加と関連しています.
- インスリン類似成長因子1受容体 (IGF1R) はT2DとNDの病原性に関与し,神経炎症と神経細胞生存に影響する.
- T2DとNDの間の正確な分子関係は完全に理解されていません.
研究 の 目的:
- T2Dに関連する神経変性における治療目的で,IGF1R媒介の免疫調節経路を調査する.
- IGF1Rシグナル伝達に対する伝統的な中国医学 (TCM) と構造的な運動の組み合わせを調査する.
- T2Dによる神経変性変化を緩和するこれらの介入の可能性を評価する.
主な方法:
- アミロイドベータ (Aβ) 毒性にさらされたSH-SY5Yニューロンとマウスの原発皮質ニューロンを用いたin vitro試験.
- IGF1Rの過剰発現とCS (TCMの成分) による治療
- 細胞活性の評価,アポトーシス,炎症性サイトカイン (IL-1β,TNF-α,IL-10),酸化ストレス,およびマクロファージの極化 (M2型).
主要な成果:
- IGF1Rの発現の増加は,Aβ誘発のニューロン死亡と炎症を減少させた.
- CS治療はIL-10を上昇させ,炎症誘発性サイトカインを抑制し,M2型マクロファージの偏化を促進した.
- 強化された神経栄養因子 (BDNF) と抗炎症反応が観察されました.
結論:
- IGF1RはT2Dに関連した神経変性における神経炎症と神経細胞の死滅において重要な役割を果たします.
- 組み合わせたTCMと構造的な運動介入は,IGF1Rシグナリングを有益に調節する可能性があることを示しています.
- これらの神経保護効果と治療の可能性を確認するには,さらなる臨床研究が必要である.
さらに関連する動画
関連する概念動画
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K


